Close Menu

NEW YORK (GenomeWeb) – Qiagen said today that it has acquired molecular oncology decision company N-of-One. Terms were not disclosed, but Qiagen said it made the purchase with cash reserves.

In purchasing Concord, Massachusetts-based N-of-One, Qiagen expects to beef up its offerings in decision support and offer its customers better clinical interpretation technologies for genomic data in pursuit of new, targeted therapies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of Idaho researchers model the scientific discovery process to examine the link between reproducibility and scientific truth.

A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.

Relocating USDA agencies outside of Washington, DC, may make them less effective, critics of the move tell NPR.

In PLOS this week: genes that help Borrelia burgdorferi survive in ticks, CiliaCarta collection of about 1,000 suspected cilia genes, and more.